Hubei Biocause Pharmaceutical (000627) — Capital Reinvestment Ratio
Hubei Biocause Pharmaceutical (000627) has a Capital Reinvestment Ratio of 0.04x as of September 2023, meaning it reinvests 0% of its operating cash flow (CN¥276.06 Million) in capital expenditures (CN¥10.51 Million). See cash generation quality of Hubei Biocause Pharmaceutical to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hubei Biocause Pharmaceutical Capital Reinvestment Ratio (2001–2023)
This chart tracks Hubei Biocause Pharmaceutical's Capital Reinvestment Ratio across 16 annual periods.
Annual Capital Reinvestment Ratio for Hubei Biocause Pharmaceutical (2001–2023)
Year-by-year Capital Reinvestment Ratio for Hubei Biocause Pharmaceutical from 2001 to 2023. For live market cap and broader valuation context, see Hubei Biocause Pharmaceutical market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.01x | CN¥9.53 Billion | CN¥67.53 Million | ▼ -60.5% |
| 2022 | 0.02x | CN¥7.52 Billion | CN¥135.06 Million | ▼ -73.9% |
| 2021 | 0.07x | CN¥4.17 Billion | CN¥287.13 Million | ▲ +361.4% |
| 2020 | 0.01x | CN¥21.42 Billion | CN¥319.51 Million | ▼ -40.5% |
| 2019 | 0.03x | CN¥28.60 Billion | CN¥717.10 Million | ▲ +36.8% |
| 2018 | 0.02x | CN¥14.98 Billion | CN¥274.67 Million | ▼ -99.0% |
| 2017 | 1.80x | CN¥431.58 Million | CN¥778.95 Million | ▲ +63.8% |
| 2013 | 1.10x | CN¥130.53 Million | CN¥143.80 Million | ▼ -19.6% |
| 2012 | 1.37x | CN¥93.79 Million | CN¥128.50 Million | ▼ -38.6% |
| 2011 | 2.23x | CN¥66.95 Million | CN¥149.37 Million | ▲ +438.3% |
| 2010 | 0.41x | CN¥224.58 Million | CN¥93.09 Million | ▼ -24.1% |
| 2007 | 0.55x | CN¥118.56 Million | CN¥64.76 Million | ▼ -46.2% |
| 2006 | 1.02x | CN¥128.19 Million | CN¥130.12 Million | ▲ +101.5% |
| 2005 | 0.50x | CN¥48.66 Million | CN¥24.51 Million | ▲ +10.7% |
| 2004 | 0.46x | CN¥56.07 Million | CN¥25.52 Million | ▼ -46.0% |
| 2001 | 0.84x | CN¥37.30 Million | CN¥31.47 Million | — |